Texto: 
- bcva: 20/20 -2 ou   (low myope ou)

- color vision (pip): 10/14 od  11/14 os

- red desaturation: 90% od

- white light brightness: 75% od

- pupils: 4->3mm ou,    2+ apd od

- motility: fd & v ou

- visual fields: gross defect to confrontation 7-9 clock hours od; full os

- iop: 16 ou

- sle: normal anterior segment ou

- dfe: 
     lens/vitreous: clear ou 
     macula: +flr, flat and unremarkable ou
     a/v:
        normal caliber w/o nicking, tortuosity,                     
        attenuation, or sheathing ou
     periphery: 
        flat and unremarkable ou
     disc: 
        0.1 c/d ou w/o pallor/heme
        slightly increased fullness/elevation od, but      
        sharp disc margins/clearly-defined vessels
        single flat, hypopigmented lesion just inferior   
        to disc margin od (1/5 dd)
- trans-sphenoidal surgical debulking (uncomplicated)

- serology:
     bartonella
     lyme
     rpr/fta

- mri orbits
presumably new-onset, painless, diffuse r monocular field loss  w/ +apd and subtle abnormalities of r optic disc
large intrasellar and suprasellar mass lesion
pituitary macroadenoma - null cell (non-secreting)
-optic nerve disease:
     neuropathy: compressive/infiltrative,     
     inflammatory, ischemic, toxic
     optic nerve drusen

- retrobulbar optic neuritis 

- neuroretinitis (bartonella, syphilis, lyme)

-intracranial process:
     - mass (pit adenoma, meningioma, glioma,      
     craniopharygioma)
     - aneurysm (most likely ica)
     inflammation (sarcoid, ms)

- retinal dystrophy/degeneration:
     - fundus flavimaculatus
21 y.o. woman reservist, activated & deployed into iraq in march.

air evacuated to germany and then subsequently to wramc in mid july for dyspnea.

pulmonology evaluation made a diagnosis of asthma, and she was started on po steroid burst w/ taper, albuterol, advair and singulaire.  

r-sided visual loss (od) started shortly after initiating these asthma meds and remained stable over next 1-2 weeks.  she then reported “i can’t see person standing to my right”. 

she denied any sudden onset - but is unable to pinpoint the moment when her symptoms began nor recall what she was doing; no “falling curtain”.

- no central vision loss ou

- no vision changes os

- no floaters, photopsia or amaurosis 

- no headache, eye pain or photophobia 

- no gross neurologic symptoms (diplopia, dysarthria, weakness, parasthesias, confusion)

- pmh/psh: 
     recent asthma dx

- fh: 
     non-contributory

- social hx:
     no tobacco/rare etoh
     1 previous sexual partner 2 years ago

- meds:
     po prednisone taper (currently 20mg qd)
     albuterol
     singular
     advair
     ocp 

-allergies: 
     pcn
- 10-15% of all intracranial tumors
- normal volunteers had 10% incidence of asymptomatic adenomas by mri

- found in 1.5-27% of autopsy cases

patients present with either:
     hormonal abnormalities
     symptoms of compressive lesion: headache, field    
     defects or cranial nerve palsies (cavernous sinus  
     invasion) 

genetic association:
     men type 1: 
          30% of patients have pit adenoma
          triad with parathyroid and pancreatic islet           
          tumors
     gsp:
          gene that encodes alpha-subunit of     
          gtp-binding protein gs
          mutation leads to activation of camp
     present in:
          40% of gh-secretors
          10% of null cell (non-secretors)
          6% of acth-secretors

classification:
     based on size:
          macroadenoma > 1cm
          microadenoma < 1cm
     based on what the tumor secretes:
          prolactin, gonadotropin, gh, acth, tsh
          nothin’ (null cell)

surgery:
     for most non-prolactin secreting adenomas
     usually trans-sphenoidal:
          mortality <1%
          common complications: nasal septal            
          perforation, ant. pit insufficiency,  
          transient diabetes insipidus, csf leak
          carotid injury and vision loss are rare

     success measures clinically and radiographically
     normalization of hormones varies with type/size of   
     tumor
     normalization of visual fields = 16-53%
     improvement of visual fields = 26-70%

treatment of prolactinomas:
     medical (dopamine agonists)
     - prl secretion inhibited by dopamine secretion  
     from the hypothalamus

     - decreases tumor size      (70-90% of cases)
     - normalizes prl levels     (70-90% of cases)
     - restores ovulation/menses (70-90% of cases)
     - improves visual fields    (70-90% of cases)

     "reversible, therefore lifelong tx is rule"

drugs:
     bromocriptine (classic—used for decades)
     side effects: n/v, dizziness, postural    
     hypotension, ha’s

newer agents:
     lisuride
     pergolide
     cabergoline

new txs for non-prl adenomas:
     gh-secretors:
          somatostatin analogs: octreotide & lanreotide
          reduce gh levels in 90% of pts 
          achieve complete suppression in 50% of pts

radiation:
     usually reserved for residual dz or recurrence   
     after surgery
     average total dose = 45-50 gy
     control rates of 85-95% @ 10 years

3 types:
     standard
     stereotactic fractionated
     stereotactic radiosurgery (single dose / gamma     
     knife)

disadvantages:
      slower reversal of neurologic symptoms
      slower drop in hormonal levels
      hypopituitarism: 50% of pts will have at least     
      one pit hormone deficiency @ 5 yrs       lifelong   
      follow-up
secondary brain tumor:
      risk of 1.3-1.7% @ 10 yrs
      risk of 1.9-2.7% @ 20 yrs
      (relative risk of 9.3-16 x general population)
      radiation-induced optic neuropathy/retinopathy
      low risk: 0.7-2%

srs(stereotactic radiosurgery)
       quicker drop in hormone levels
       adverse cns effects in 28% of cases at 3 yrs    
       compared with 0% with fsrt3

       "not recommended !!"


Keywords by value: 
- ou: 0.08788411439118786 (22876)
- -: 0.07420648340183136 (21459)
- :: 0.06024919061783929 (11095)
- %: 0.05312689321284668 (2175)
- od: 0.0505342999238408 (7546)
- pit: 0.03168112606757615 (1451)
- 70-90: 0.03168112606757615 (7)
- @: 0.02665487874842201 (27)
- yrs: 0.02308878909298227 (42)
- null: 0.0230471658151356 (10)
- visual: 0.02064965885584858 (597)
- fields: 0.019857720002587745 (73)
- pts: 0.0189503624714403 (74)
- gh-secretors: 0.018796414550035178 (2)
- prl: 0.018796414550035178 (3)
- stereotactic: 0.018613388540764948 (24)
- (: 0.018482602803680866 (9594)
- ): 0.018256827943197572 (10569)
- cases: 0.01820987759476204 (558)
- adenomas: 0.018166388725066148 (87)
- dopamine: 0.017318488791911626 (5)
- disc: 0.016969025658912666 (1791)
- optic: 0.016868682386374526 (368)
- vision: 0.016835752552285355 (241)
- trans-sphenoidal: 0.016453957644559463 (4)
- os: 0.01631752566288547 (27238)
- flat: 0.01601979509870846 (236)
- bartonella: 0.015840563033788075 (5)
- advair: 0.0153647772100904 (6)
- asthma: 0.01509970318255138 (93)
- levels: 0.01504158376661818 (281)
- gh: 0.014976031886435912 (14422)
- taper: 0.014647352398531311 (45)
- normalization: 0.014647352398531311 (8)
- slower: 0.014647352398531311 (9)
- lifelong: 0.014362637275664525 (9)
- =: 0.014343662314542113 (1160)
- radiosurgery: 0.013683631452384068 (13)
- albuterol: 0.013498106128312362 (19)
- secretion: 0.013498106128312362 (40)
- risk: 0.013199175468482245 (538)
- hormonal: 0.013022320304614686 (20)
- 10: 0.012284111847961238 (1995)
- !: 0.012205705694260516 (28)
- macroadenoma: 0.01202018037018881 (50)
- ,: 0.011544139254468545 (45533)
- 1cm: 0.011341174546908353 (59)
- lyme: 0.011277522173454875 (40)
- meds: 0.011215715058586534 (87)
- drop: 0.011215715058586534 (174)
- effects: 0.010633000058587213 (60)
- loss: 0.010577672377264135 (858)
- po: 0.010412991026102712 (15449)
- hormone: 0.010330973369753468 (90)
- w/o: 0.010291118075484485 (75)
- she: 0.010229365208759797 (2424)
- nerve: 0.009847375671068144 (856)
- what: 0.009619303477105177 (210)
- &: 0.00959932161665703 (872)
- dose: 0.0095345693008802 (149)
- w/: 0.009453074177596197 (285)
- myope: 0.009398207275017589 (1)
- 10/14: 0.009398207275017589 (1)
- 11/14: 0.009398207275017589 (1)
- 4-: 0.009398207275017589 (454)
- 7-9: 0.009398207275017589 (4)
- lens/vitreous: 0.009398207275017589 (1)
- +flr: 0.009398207275017589 (1)
- a/v: 0.009398207275017589 (12)
- nicking: 0.009398207275017589 (1)
- sheathing: 0.009398207275017589 (1)
- c/d: 0.009398207275017589 (4)
- pallor/heme: 0.009398207275017589 (1)
- fullness/elevation: 0.009398207275017589 (1)
- margins/clearly-defined: 0.009398207275017589 (1)
- rpr/fta: 0.009398207275017589 (1)
- +apd: 0.009398207275017589 (1)
- compressive/infiltrative: 0.009398207275017589 (1)
- neuroretinitis: 0.009398207275017589 (1)
- dystrophy/degeneration: 0.009398207275017589 (1)
- flavimaculatus: 0.009398207275017589 (1)
- reservist: 0.009398207275017589 (1)
- singulaire: 0.009398207275017589 (1)
- curtain: 0.009398207275017589 (1)
- floaters: 0.009398207275017589 (1)
- photopsia: 0.009398207275017589 (1)
- amaurosis: 0.009398207275017589 (1)
- tobacco/rare: 0.009398207275017589 (1)
- -allergies: 0.009398207275017589 (1)
- pcn: 0.009398207275017589 (3)
- volunteers: 0.009398207275017589 (1)
- 1.5-27: 0.009398207275017589 (1)
- gsp: 0.009398207275017589 (2)
- alpha-subunit: 0.009398207275017589 (1)
- gtp-binding: 0.009398207275017589 (1)
- non-secretors: 0.009398207275017589 (1)
- acth-secretors: 0.009398207275017589 (1)
- secretes: 0.009398207275017589 (1)
- nothin: 0.009398207275017589 (11)
- non-prolactin: 0.009398207275017589 (1)
- type/size: 0.009398207275017589 (1)
- 16-53: 0.009398207275017589 (1)
- 26-70: 0.009398207275017589 (1)
- restores: 0.009398207275017589 (1)
- ovulation/menses: 0.009398207275017589 (1)
- classic—used: 0.009398207275017589 (1)
- lisuride: 0.009398207275017589 (1)
- pergolide: 0.009398207275017589 (1)
- cabergoline: 0.009398207275017589 (1)
- txs: 0.009398207275017589 (1)
- non-prl: 0.009398207275017589 (1)
- lanreotide: 0.009398207275017589 (1)
- fractionated: 0.009398207275017589 (5)
- 1.3-1.7: 0.009398207275017589 (1)
- 1.9-2.7: 0.009398207275017589 (1)
- 9.3-16: 0.009398207275017589 (1)
- neuropathy/retinopathy: 0.009398207275017589 (1)
- 0.7-2: 0.009398207275017589 (1)
- srs: 0.009398207275017589 (1)
- fsrt3: 0.009398207275017589 (1)
- field: 0.009349043976808495 (213)
- symptoms: 0.009081694997433429 (1259)
- gross: 0.008679288476765988 (237)
- bcva: 0.008659244395955813 (2)
- brightness: 0.008659244395955813 (2)
- dfe: 0.008659244395955813 (3)
- monocular: 0.008659244395955813 (2)
- non-secreting: 0.008659244395955813 (2)
- -intracranial: 0.008659244395955813 (3)
- craniopharygioma: 0.008659244395955813 (2)
- encodes: 0.008659244395955813 (2)
- prolactinomas: 0.008659244395955813 (2)
- inhibited: 0.008659244395955813 (2)
- normalizes: 0.008659244395955813 (2)
- 45-50: 0.008659244395955813 (4)
- 85-95: 0.008659244395955813 (2)
- 90: 0.008588543030244035 (326)
- tumor: 0.0084956601348009 (2333)
- r: 0.008275148168093403 (401867)
- -2: 0.008226978822279732 (427)
- apd: 0.008226978822279732 (9)
- fd: 0.008226978822279732 (92)
- macula: 0.008226978822279732 (16)
- 1/5: 0.008226978822279732 (9)
- -optic: 0.008226978822279732 (21)
- activated: 0.008226978822279732 (8)
- r-sided: 0.008226978822279732 (5)
- pinpoint: 0.008226978822279732 (4)
- partner: 0.008226978822279732 (4)
- singular: 0.008226978822279732 (3)
- gs: 0.008226978822279732 (2543)
- ant: 0.008226978822279732 (7482)
- disadvantages: 0.008226978822279732 (5)
- radiation-induced: 0.008226978822279732 (3)
- quicker: 0.008226978822279732 (3)
- ’: 0.008168529018055828 (1174)
- started: 0.008127019441409465 (182)
- confrontation: 0.007920281516894037 (6)
- moment: 0.007920281516894037 (6)
- 20mg: 0.007920281516894037 (5)
- ocp: 0.007920281516894037 (14)
- somatostatin: 0.007920281516894037 (7)
- analogs: 0.007920281516894037 (5)
- dd: 0.0076823886050452 (2482)
- initiating: 0.0076823886050452 (5)
- pmh/psh: 0.0076823886050452 (5)
- agonists: 0.0076823886050452 (8)
- hypopituitarism: 0.0076823886050452 (8)
- adenoma: 0.007608729961206849 (638)
- neurologic: 0.007608729961206849 (446)
- clock: 0.007488015943217956 (31)
- drusen: 0.007488015943217956 (12)
- camp: 0.007488015943217956 (33)
- gonadotropin: 0.007488015943217956 (8)
- insipidus: 0.007488015943217956 (9)
- bromocriptine: 0.007488015943217956 (7)
- achieve: 0.007488015943217956 (40)
- single: 0.007385203178017978 (287)
- cell: 0.007382432979471705 (1988)
- iop: 0.0073236761992656555 (1167)
- hypopigmented: 0.0073236761992656555 (7)
- germany: 0.0073236761992656555 (7)
- pulmonology: 0.0073236761992656555 (9)
- parasthesias: 0.0073236761992656555 (8)
- activation: 0.0073236761992656555 (15)
- gy: 0.0073236761992656555 (1777)
- desaturation: 0.007181318637832263 (15)
- retrobulbar: 0.007181318637832263 (11)
- palsies: 0.007181318637832263 (8)
- hormones: 0.007181318637832263 (10)
- octreotide: 0.007181318637832263 (14)
- serology: 0.007055750369541874 (9)
- intrasellar: 0.007055750369541874 (14)
- burst: 0.007055750369541874 (27)
- microadenoma: 0.007055750369541874 (23)
- n/v: 0.007055750369541874 (17)
- newer: 0.007055750369541874 (9)
- <: 0.00703212265991853 (613)
- based: 0.006948167083724862 (378)
- new-onset: 0.006943425725983425 (10)
- fh: 0.006943425725983425 (30)
- sexual: 0.006943425725983425 (26)
- acth: 0.006943425725983425 (15)
- 50: 0.006931765493910031 (678)
- tumors: 0.006843744899084223 (533)
- 20/20: 0.006841815726192034 (18)
- wramc: 0.006841815726192034 (11)
- improves: 0.006841815726192034 (11)
- “: 0.00680490600805791 (463)
- ”: 0.006766761946755617 (473)
- tortuosity: 0.006749053064156181 (16)
- iraq: 0.006749053064156181 (16)
- recall: 0.006749053064156181 (38)
- secreting: 0.006749053064156181 (20)
- abnormalities: 0.006692461879953553 (356)
- 0.1: 0.006663719687105502 (104)
- dz: 0.006663719687105502 (18)
- motility: 0.00658471332020388 (25)
- islet: 0.00658471332020388 (22)
- adverse: 0.00658471332020388 (16)
- prolactin: 0.006511160152307343 (35)
- 1: 0.0065031760169287 (15898)
- then: 0.006483937907083347 (489)
- debulking: 0.006442355758770487 (19)
- autopsy: 0.006442355758770487 (20)
- hypothalamus: 0.006442355758770487 (21)
- no: 0.0064212250052522535 (35870)
- my: 0.0063167874904801 (3572)
- dysarthria: 0.0063167874904801 (21)
- postural: 0.006259146529637588 (27)
- headache: 0.00625796468564136 (758)
- 10-15: 0.006204462846921649 (24)
- decreases: 0.006204462846921649 (20)
- suppression: 0.006204462846921649 (31)
- pip: 0.006152447746527798 (293)
- triad: 0.006152447746527798 (26)
- size: 0.0061084773376946086 (636)
- presumably: 0.006102852847130258 (23)
- syphilis: 0.006102852847130258 (27)
- retinal: 0.006102852847130258 (40)
- evacuated: 0.006102852847130258 (26)
- gene: 0.006102852847130258 (1895)
- reversible: 0.006102852847130258 (46)
- ha: 0.006055462908355382 (23792)
- reserved: 0.006055462908355382 (73)
- >: 0.006053662078184572 (1162)
- unremarkable: 0.006032124560089681 (465)
- 3mm: 0.006010090185094405 (55)
- deployed: 0.006010090185094405 (26)
- qd: 0.006010090185094405 (58)
- dx: 0.005966569935072811 (142)
- etoh: 0.005966569935072811 (25)
- varies: 0.005966569935072811 (65)
- orbits: 0.005924756808043726 (35)
- march: 0.005884521916804018 (49)
- july: 0.005884521916804018 (32)
- person: 0.005884521916804018 (63)
- reversal: 0.005884521916804018 (29)
- decades: 0.005845750441142105 (30)
- mutation: 0.005808339652430728 (66)
- neuritis: 0.005772197273245567 (41)
- parathyroid: 0.005772197273245567 (253)
- knife: 0.005737240106056879 (39)
- compressive: 0.005638761086727438 (47)
- tx: 0.005638761086727438 (55)
- neuropathy: 0.005607857529293267 (80)
- photophobia: 0.005607857529293267 (35)
- hypotension: 0.005577824611418324 (46)
- lesion: 0.005566807759063288 (3600)
- success: 0.005548614617614364 (196)
- usually: 0.005532896063681789 (770)
- gamma: 0.005520183650575813 (49)
- confusion: 0.005465499967859873 (43)
- leak: 0.005465499967859873 (141)
- 0: 0.005465499967859873 (11370)
- sle: 0.005439175220961824 (269)
- doing: 0.005413484867466023 (45)
- prednisone: 0.005388399049331488 (50)
- caliber: 0.005363889968068482 (52)
- years: 0.005350198586393353 (760)
- toxic: 0.0053399316995694866 (175)
- ica: 0.0053399316995694866 (13967)
- agents: 0.0053399316995694866 (55)
- or: 0.005338607403857716 (60128)
- diplopia: 0.005316500029293607 (51)
- social: 0.005316500029293607 (63)
- average: 0.005316500029293607 (57)
- rates: 0.005293572305177441 (1648)
- fundus: 0.00527112730603263 (67)
- 1-2: 0.005227607056011036 (106)
- classification: 0.005206495513051356 (86)
- shortly: 0.0051857939289819514 (58)
- falling: 0.0051455590377422426 (56)
- men: 0.0051455590377422426 (11914)
- reduce: 0.0051455590377422426 (162)
- uncomplicated: 0.0051259970562196455 (59)
- periphery: 0.005087918076899732 (70)
- leads: 0.005087918076899732 (69)
- low: 0.005066456402700212 (6753)
- radiographically: 0.005033234394183793 (68)
- drugs: 0.005033234394183793 (71)
- v: 0.004998277226995103 (59120)
- pupils: 0.004981219293789942 (64)
- genetic: 0.004981219293789942 (124)
- suprasellar: 0.004964430000646936 (91)
- remained: 0.004964430000646936 (73)
- mortality: 0.004964430000646936 (75)
- septal: 0.004964430000646936 (144)
- tsh: 0.004947901017133114 (97)
- sharp: 0.0049316243943924015 (108)
- transient: 0.0049316243943924015 (98)
- deficiency: 0.004915592542191399 (106)
- dizziness: 0.004884234455617525 (85)
- ms: 0.004868894650231491 (3435)
- nor: 0.004868894650231491 (5303)
- standing: 0.004853772438086549 (131)
- insufficiency: 0.0048388617323565485 (105)
- steroid: 0.004809651738552589 (321)
- red: 0.004753528355305871 (4203)
- population: 0.004753528355305871 (110)
- patients: 0.004715510872848669 (1457)
- perforation: 0.004687289782697121 (158)
- sarcoid: 0.004674521988404247 (356)
- protein: 0.004674521988404247 (222)
- 75: 0.004661905295816825 (204)
- 2+: 0.004661905295816825 (138)
- standard: 0.004661905295816825 (112)
- cns: 0.004661905295816825 (119)
- types: 0.004649436170269712 (147)
- next: 0.004624927089006707 (97)
- began: 0.004612880654834071 (110)
- painless: 0.004577537150231831 (102)
- pituitary: 0.004566011653319021 (251)
- least: 0.004566011653319021 (109)
- residual: 0.0045211166795982045 (125)
- hx: 0.004510182244451946 (200)
- nasal: 0.004510182244451946 (273)
- diabetes: 0.004510182244451946 (126)
- /: 0.004499358820716321 (9607)
- ``: 0.004477899867018799 (0)
- pancreatic: 0.004457131594602199 (286)
- color: 0.0044468310499201765 (204)
- ischemic: 0.0044366290765554105 (166)
- denied: 0.0044366290765554105 (126)
- association: 0.004426523805814959 (151)
- surgery: 0.004424305041279904 (1277)
- '': 0.0043917899829045695 (0)
- invasion: 0.00438703417715787 (140)
- relative: 0.004339644238382994 (344)
- ;: 0.004318595284547108 (2912)
- dyspnea: 0.004312189551706645 (137)
- therefore: 0.00430319289003728 (137)
- 28: 0.004294271515122018 (276)
- margin: 0.004285424177366479 (394)
- normal: 0.004284474801489662 (4858)
- 3: 0.004266472338393475 (8405)
- light: 0.004250751265100423 (622)
- improvement: 0.004250751265100423 (161)
- cavernous: 0.0042254671215851605 (242)
- t: 0.004217170596593631 (523526)
- sudden: 0.004208938138071339 (155)
- unable: 0.004208938138071339 (148)
- most: 0.004206471517543872 (1722)
- mri: 0.004186089242888315 (1820)
- subtle: 0.004184615453885655 (153)
- defects: 0.004184615453885655 (191)
- incidence: 0.0041766296631296235 (176)
- control: 0.004153025051320227 (246)
- subsequently: 0.0041299317711697165 (152)
- 16: 0.004122343852439584 (559)
- 21: 0.004122343852439584 (409)
- present: 0.0041151572578500654 (4525)
- glioma: 0.004107328138279948 (411)
- carotid: 0.004085193819038552 (322)
- in: 0.004043257005610122 (113220)
- clinically: 0.003994258232138877 (178)
- segment: 0.003974330585004386 (438)
- recurrence: 0.003974330585004386 (207)
- either: 0.003967769960724665 (205)
- cranial: 0.003961249462838272 (530)
- have: 0.0039454969687955045 (1751)
- full: 0.0039355591093424725 (436)
- total: 0.003922942416755049 (259)
- measures: 0.0038981483206310973 (221)
- for: 0.0038865039906328096 (12260)
- but: 0.00388593454378153 (2727)
- inflammation: 0.0038739177757722955 (226)
- compared: 0.003856099565778969 (215)
- intracranial: 0.0038502257322917937 (292)
- general: 0.003838574271170056 (459)
- 40: 0.0038327959476419757 (508)
- eye: 0.0038213324169636582 (547)
- mid: 0.003809990841052085 (1642)
- just: 0.0038043649806034246 (247)
- csf: 0.0038043649806034246 (332)
- rule: 0.0038043649806034246 (333)
- recommended: 0.0037766725643952575 (231)
- after: 0.00376972537869766 (1714)
- i: 0.0037657939181540614 (513494)
- stable: 0.0037550251591066163 (297)
- of: 0.003726134353880227 (41955)
- slightly: 0.003682543985348692 (266)
- vessels: 0.003667633279618692 (276)
- attenuation: 0.0036627090303049453 (324)
- made: 0.0036288618039567785 (273)
- currently: 0.00360999231877618 (269)
- complications: 0.00360999231877618 (280)
- aneurysm: 0.0036006813593212183 (855)
- hours: 0.0035822999025680135 (312)
- previous: 0.003537686778969399 (523)
- rare: 0.003537686778969399 (488)
- process: 0.0035075324998237894 (446)
- meningioma: 0.0035032935356663912 (444)
- 30: 0.0035032935356663912 (631)
- defect: 0.0034101783862472567 (623)
- ago: 0.0033909688921079408 (425)
- weakness: 0.0033833809733778085 (434)
- clear: 0.003368365259218172 (660)
- non-contributory: 0.00336464414520989 (287)
- sinus: 0.003331725980429038 (907)
- reported: 0.0033209753204432963 (474)
- 20: 0.0032756025971823195 (2416)
- complete: 0.003206157712138651 (705)
- to: 0.0031870754361416885 (40381)
- new: 0.0031746140477617894 (569)
- inflammatory: 0.0031591854415693216 (519)
- side: 0.0031561263345032736 (2155)
- inferior: 0.0030909556091248003 (623)
- air: 0.003082369537901883 (1776)
- asymptomatic: 0.0030795228123625664 (453)
- type: 0.0030710279619903095 (949)
- recent: 0.00306260026528763 (581)
- by: 0.0030338398789869396 (2984)
- white: 0.0030214330625927695 (558)
- x: 0.0030054012103917665 (21286)
- central: 0.002997474794093773 (709)
- radiation: 0.0029896068758660304 (533)
- follow-up: 0.0029637921017502578 (523)
- injury: 0.0029042734988153516 (916)
- onset: 0.0028757155926707354 (524)
- found: 0.0028710294397144053 (642)
- any: 0.002868694065109055 (1117)
- will: 0.0028501929833466334 (776)
- medical: 0.002803102132266529 (618)
- diffuse: 0.0027580036464555594 (824)
- brain: 0.0027413129246298103 (978)
- her: 0.0027392448384700803 (13092)
- 6: 0.0027208104065830217 (5312)
- see: 0.002718781675083996 (2684)
- 5: 0.002665416228618511 (8237)
- evaluation: 0.0026463100168729295 (786)
- y.o: 0.0026294023801563967 (586)
- s: 0.0026127587069451888 (414481)
- changes: 0.002610925347798572 (828)
- when: 0.0026090951360511786 (851)
- weeks: 0.0025855839625811817 (793)
- all: 0.00257667749406321 (11660)
- likely: 0.00256960550739409 (930)
- secondary: 0.0025469402628025667 (822)
- mass: 0.002534031997756001 (5255)
- one: 0.0024687967839132664 (7087)
- at: 0.002468578151026936 (83424)
- common: 0.002384080183322385 (1580)
- these: 0.0023708365585904476 (1129)
- anterior: 0.0023462610061436434 (1421)
- over: 0.0023194483903411114 (1978)
- on: 0.002315216457458725 (91641)
- increased: 0.0022286618142853473 (1255)
- into: 0.0021677253389762335 (1299)
- and: 0.0021109798113586385 (31978)
- was: 0.0021072015399012513 (7680)
- woman: 0.002104374144444463 (987)
- diagnosis: 0.002091918263092132 (1487)
- can: 0.00206633513056404 (6061)
- large: 0.0019920495008860124 (2420)
- had: 0.0019657247539879618 (2121)
- 2: 0.0019617318726125226 (13754)
- surgical: 0.0019149485823576264 (1704)
- treatment: 0.001843941321536127 (1790)
- that: 0.0015735402223441613 (3273)
- disease: 0.0014890592123834798 (3336)
- from: 0.0013501446835332753 (3282)
- not: 0.001316437816356008 (5583)
- are: 0.0012418698001381682 (8518)
- is: 0.0011989142396262805 (65037)
- pain: 0.0011125886647449198 (5051)
- right: 0.0009612278348725124 (8044)
- with: 0.0006236896380058089 (23954)
- the: 0.0004421618913762019 (67588)
- a: 0.00042281428765309306 (549576)
- .: 0.0003027678984848296 (82185)
